Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients.

about

Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Gestational diabetes mellitus and type 2 diabetes: same disease in a different moment of life? Maybe not

P2860

Q33862472-82B6EE62-8F9B-477A-9FEE-23E4AAEE6713 Q57831118-EC4C2EB5-78AA-46E6-915A-087753F1E9AB

P2860

Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients.

Item

http://www.wikidata.org/entity/Q51127315

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serum Fluorescent Advanced Gly ...... gestational diabetes patients.

@en

Serum Fluorescent Advanced Glycation End

@nl

type

Item

label

Serum Fluorescent Advanced Gly ...... gestational diabetes patients.

@en

Serum Fluorescent Advanced Glycation End

@nl

prefLabel

Serum Fluorescent Advanced Gly ...... gestational diabetes patients.

@en

Serum Fluorescent Advanced Glycation End

@nl

P1476

Serum Fluorescent Advanced Gly ...... gestational diabetes patients

@en

P2093

Catiane Pompilio Brescansin

http://www.w3.org/2001/XMLSchema#string

Dayane Alberton

http://www.w3.org/2001/XMLSchema#string

Emanuel Maltempi de Souza

http://www.w3.org/2001/XMLSchema#string

João Paulo Lobo

http://www.w3.org/2001/XMLSchema#string

Marciane Welter

http://www.w3.org/2001/XMLSchema#string

P2860

Renal catabolism of advanced glycation end products: the fate of pentosidine

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Advanced glycation end-products: a review.

Advanced glycation end products: sparking the development of diabetic vascular injury.

Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies.

Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins.

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.

P304

233-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/2359-3997000000238

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabiane Gomes de Moraes Rego

Geraldo Picheth

Izabella Castilhos Ribeiro Santos-Weiss

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28225992

http://www.w3.org/2001/XMLSchema#string

P921

gestational diabetes

Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients.

about

P2860

P2860

Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921